What is Coronary Artery Disease & Cardiac Interventions?
Coronary artery disease intervention portfolio: Atlas coronary stents, drug-eluting PTCA balloons, guidewires, rotablation, guiding catheters, and renal denervation systems.
Who manufactures Coronary Artery Disease & Cardiac Interventions devices?
INVAMED develops and manufactures a complete range of coronary artery disease & cardiac interventions devices at its manufacturing and research campus in Ankara, Turkey, with a U.S. office at One World Trade Center, New York. INVAMED technologies are used by physicians across international markets.
Coronary Artery Disease & Cardiac Interventions product portfolio
The INVAMED coronary artery disease & cardiac interventions portfolio includes: Extender 약물 방출 PTCA 풍선 카테터 Paclitaxel, Extender PTCA 풍선 카테터, Atlas Coronary 스텐트 시스템 Cobalt Chromium, Atlas Coronary 스텐트 시스템 Stainless Steel, Atlas Coronary 스텐트 그라프트 System, Lotus Single Lumen & Double Lumen (RX) PTCA 마이크로 카테터, AngioCATH 가이딩 카테터, GuideX 연장 카테터, SteerCATH 조향형 카테터, InWIRE PTCA 가이드와이어, TemREN 회전식 죽종절제술 시스템, Delta 신장 신경차단 시스템, Keeper 혈관 내 올가미, AngioTEN 폐쇄 장치.
Frequently Asked Questions about Coronary Artery Disease & Cardiac Interventions
What is a drug-eluting coronary stent (DES)?
A DES is a metallic coronary stent coated with anti-proliferative drug preventing neointimal hyperplasia and restenosis after PCI. INVAMED ATLAS DES uses a thin-strut cobalt-chromium platform with polymer-based drug delivery.
When is rotational atherectomy needed?
Rotational atherectomy is indicated for heavily calcified coronary lesions that cannot be crossed or dilated with standard balloons. TemREN diamond-coated burrs ablate calcified plaque while preserving elastic tissue.
What is a guide extension catheter used for?
A guide extension catheter telescopes through the guiding catheter to provide deep-vessel backup support, extending reach into distal, tortuous, or calcified segments. Essential for complex PCI.
How does a drug-eluting balloon differ from a stent?
A DEB delivers drug to the vessel wall during inflation without leaving a permanent implant. Primary use: in-stent restenosis treatment and small vessel disease where stent placement is undesirable.